ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

December 17, 2013

DCPC Faces Huge Out Year Costs Of Four Trials

February 15, 1991

NCI, IOM Called To Congress to Explain Divergent Positions On Minority Research

January 29, 1999

AAAS Urges Bush To Continue Funding For Stem Cell Research; ONS Hires Arent Fox.

March 9, 2001

Clearinghouse Completes Review of Backlog, Funds What Caused It, Reports On Program Value

May 19, 1978

NCI Plans Conference On DES Late Effects, Reproductive Cancers

November 29, 1991